Cargando…
Recurrent erysipelas - risk factors and clinical presentation
BACKGROUND: Erysipelas is a common infection that often recurs, but the impact of specific risk factors for reoccurrence remains elusive. In the present study we aimed at clarifying predisposing conditions for reoccurrence. METHODS: Medical records were reviewed from all patients ≥18 years of age di...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033615/ https://www.ncbi.nlm.nih.gov/pubmed/24884840 http://dx.doi.org/10.1186/1471-2334-14-270 |
_version_ | 1782317849521422336 |
---|---|
author | Inghammar, Malin Rasmussen, Magnus Linder, Adam |
author_facet | Inghammar, Malin Rasmussen, Magnus Linder, Adam |
author_sort | Inghammar, Malin |
collection | PubMed |
description | BACKGROUND: Erysipelas is a common infection that often recurs, but the impact of specific risk factors for reoccurrence remains elusive. In the present study we aimed at clarifying predisposing conditions for reoccurrence. METHODS: Medical records were reviewed from all patients ≥18 years of age diagnosed with erysipelas at the Department of Infectious Diseases at Skåne University Hospital, Sweden, from January 2007 to February 2011. 502 patients were included, of which 357 were single episode erysipelas and 145 had recurrent erysipelas. These two groups were compared regarding underlying conditions and clinical presentation. RESULTS: Erysipelas in the lower limbs had the greatest propensity of recurrence. The associations between underlying conditions and recurrence were largely depending on the site of erysipelas. Overall, the most prominent risk factor for recurrence was lymphedema and other conditions causing a chronic impairment of the defence against microbes. Conditions temporarily disrupting the skin barrier (e.g. a local wound or toe web intertrigo), although likely being risk factors for erysipelas per se, did not seem to predispose to repeated episodes. Individuals with recurrent erysipelas tended to seek medical attention earlier, and were less likely to be hospitalized or receive intravenous antibiotics, but there was no evidence of any difference in inflammatory reaction when taking confounding factors into account. CONCLUSIONS: In this large cross-sectional study of over 500 patients with erysipelas, lymphedema was the most prominent risk factors for recurrence although the distribution of predisposing conditions varies depending on the site of erysipelas. |
format | Online Article Text |
id | pubmed-4033615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40336152014-05-27 Recurrent erysipelas - risk factors and clinical presentation Inghammar, Malin Rasmussen, Magnus Linder, Adam BMC Infect Dis Research Article BACKGROUND: Erysipelas is a common infection that often recurs, but the impact of specific risk factors for reoccurrence remains elusive. In the present study we aimed at clarifying predisposing conditions for reoccurrence. METHODS: Medical records were reviewed from all patients ≥18 years of age diagnosed with erysipelas at the Department of Infectious Diseases at Skåne University Hospital, Sweden, from January 2007 to February 2011. 502 patients were included, of which 357 were single episode erysipelas and 145 had recurrent erysipelas. These two groups were compared regarding underlying conditions and clinical presentation. RESULTS: Erysipelas in the lower limbs had the greatest propensity of recurrence. The associations between underlying conditions and recurrence were largely depending on the site of erysipelas. Overall, the most prominent risk factor for recurrence was lymphedema and other conditions causing a chronic impairment of the defence against microbes. Conditions temporarily disrupting the skin barrier (e.g. a local wound or toe web intertrigo), although likely being risk factors for erysipelas per se, did not seem to predispose to repeated episodes. Individuals with recurrent erysipelas tended to seek medical attention earlier, and were less likely to be hospitalized or receive intravenous antibiotics, but there was no evidence of any difference in inflammatory reaction when taking confounding factors into account. CONCLUSIONS: In this large cross-sectional study of over 500 patients with erysipelas, lymphedema was the most prominent risk factors for recurrence although the distribution of predisposing conditions varies depending on the site of erysipelas. BioMed Central 2014-05-18 /pmc/articles/PMC4033615/ /pubmed/24884840 http://dx.doi.org/10.1186/1471-2334-14-270 Text en Copyright © 2014 Inghammar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Inghammar, Malin Rasmussen, Magnus Linder, Adam Recurrent erysipelas - risk factors and clinical presentation |
title | Recurrent erysipelas - risk factors and clinical presentation |
title_full | Recurrent erysipelas - risk factors and clinical presentation |
title_fullStr | Recurrent erysipelas - risk factors and clinical presentation |
title_full_unstemmed | Recurrent erysipelas - risk factors and clinical presentation |
title_short | Recurrent erysipelas - risk factors and clinical presentation |
title_sort | recurrent erysipelas - risk factors and clinical presentation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033615/ https://www.ncbi.nlm.nih.gov/pubmed/24884840 http://dx.doi.org/10.1186/1471-2334-14-270 |
work_keys_str_mv | AT inghammarmalin recurrenterysipelasriskfactorsandclinicalpresentation AT rasmussenmagnus recurrenterysipelasriskfactorsandclinicalpresentation AT linderadam recurrenterysipelasriskfactorsandclinicalpresentation |